International Patterns and Trends in Endometrial Cancer Incidence, 1978-2013.

Background Cancers of the corpus uteri-primarily of the endometrium-rank as the sixth most common neoplasm in women worldwide. Analyses of the global patterns and trends of uterine cancer rates are needed in view of the ongoing obesity epidemic, a major risk factor for the disease. Methods Data on endometrial cancer (ICD-10 C54) incidence from population-based cancer registries in 43 populations, published in CI5plus or by registries, were extracted for 1978 to 2013. Age-standardized incidence rates were computed for all ages and for pre- (25-49 years) and postmenopausal ages (50 years and older). Temporal trends were assessed with Joinpoint analysis, and the effects of birth cohort and year of diagnosis on the overall trends were examined using age-period-cohort modeling. Results In 2006 to 2007, rates varied 10-fold across countries. The highest rates were in North America, Eastern and Northern Europe (19 cases per 100 000 among whites in the United States, 95% confidence interval [CI] = 18 to 20, and in Slovakia, 95% CI = 18 to 21), and the lowest rates were in middle-income countries (South Africa 1, 95% CI = 0 to 3, and India 3, 95% CI = 3 to 4). Rates during the most recent 10 data years increased in 26 of the 43 populations considered in this study, with South Africa and several countries in Asia showing the largest increase. The risk of endometrial cancer increased both in consecutive generations and over time in 11 of 23 populations, with the increases more pronounced in Japan, the Philippines, Belarus, Singapore, Costa Rica, and New Zealand. Conclusions Endometrial cancer incidence rates increased over time and in successive generations in several countries, especially in those countries with rapid socioeconomic transitions.

[1]  R. Tiwari,et al.  (www.interscience.wiley.com) DOI: 10.1002/sim.3733 Estimating average annual per cent change in trend analysis , 2022 .

[2]  K. Lu,et al.  Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Richard Stevens,et al.  Endometrial cancer and oral contraceptives: an individual participant meta-analysis of 27 276 women with endometrial cancer from 36 epidemiological studies. , 2015, The Lancet. Oncology.

[4]  L. Ries,et al.  Trends in Endometrial Cancer Incidence by Race and Histology with a Correction for the Prevalence of Hysterectomy, SEER 1992 to 2008 , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[5]  R. Luoto,et al.  Effect of hysterectomy on incidence trends of endometrial and cervical cancer in Finland 1953–2010 , 2004, British Journal of Cancer.

[6]  F. Bray,et al.  Geographic and temporal variations in cancer of the corpus uteri: Incidence and mortality in pre‐ and postmenopausal women in Europe , 2005, International journal of cancer.

[7]  A. Jemal,et al.  State-Level Uterine Corpus Cancer Incidence Rates Corrected for Hysterectomy Prevalence, 2004 to 2008 , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[8]  J. Lortet-Tieulent,et al.  Convergence of decreasing male and increasing female incidence rates in major tobacco-related cancers in Europe in 1988-2010. , 2015, European journal of cancer.

[9]  F. Bray,et al.  Endometrial Cancer Incidence Trends in Europe: Underlying Determinants and Prospects for Prevention , 2005, Cancer Epidemiology Biomarkers & Prevention.

[10]  P. Rosenberg,et al.  A Web Tool for Age–Period–Cohort Analysis of Cancer Incidence and Mortality Rates , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[11]  K. Hemminki,et al.  Does the time interval between first and last birth influence the risk of endometrial and ovarian cancer? , 2011, European journal of cancer.

[12]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[13]  C. Friedenreich,et al.  Intrauterine devices and endometrial cancer risk: A pooled analysis of the Epidemiology of Endometrial Cancer Consortium , 2014, International journal of cancer.

[14]  M. Pike,et al.  Type I and II endometrial cancers: have they different risk factors? , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  F. Bray,et al.  Endometrial cancer incidence trends in Norway during 1953–2007 and predictions for 2008–2027 , 2010, International journal of cancer.

[16]  Gretchen A. Stevens,et al.  Global burden of cancer attributable to high body-mass index in 2012: a population-based study. , 2015, The Lancet. Oncology.

[17]  I. Hussain,et al.  The incidence rate of corpus uteri cancer among females in Saudi Arabia: an observational descriptive epidemiological analysis of data from Saudi Cancer Registry 2001–2008 , 2014, International journal of women's health.

[18]  F. Bray,et al.  Trends in corpus uteri cancer mortality in member states of the European Union. , 2014, European journal of cancer.

[19]  M. Søgaard,et al.  Global epidemiology of hysterectomy: possible impact on gynecological cancer rates. , 2015, American journal of obstetrics and gynecology.

[20]  Kresimir Milas,et al.  Malignant neoplasms of breast and female genital organs (C50, C51-C58) in the Osijek-Baranja County, Croatia. , 2014, Collegium antropologicum.

[21]  H. Verkooijen,et al.  The incidence of breast cancer and changes in the use of hormone replacement therapy: a review of the evidence. , 2009, Maturitas.

[22]  Matthias Doepke,et al.  Accounting for Fertility Decline During the Transition to Growth , 2003 .

[23]  B. Stewart,et al.  World cancer report 2014. , 2014 .

[24]  Alan D. Lopez,et al.  Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2014, The Lancet.

[25]  B. Yeole Trends in cancer incidence in female breast, cervix uteri, corpus uteri, and ovary in India. , 2008, Asian Pacific journal of cancer prevention : APJCP.

[26]  N. S. Murthy,et al.  Increase in incidence of cancer of corpus uteri: estimation of time trends – an Indian scenario , 2011, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[27]  V. Beral Ovarian cancer and hormone replacement therapy in the Million Women Study , 2007, The Lancet.

[28]  Gretchen A. Stevens,et al.  National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants , 2011, The Lancet.

[29]  Susheela Singh,et al.  Trends in contraceptive need and use in developing countries in 2003, 2008, and 2012: an analysis of national surveys , 2013, The Lancet.

[30]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[31]  Kari Kuulasmaa,et al.  Use of oral contraceptives and hormone replacement therapy in the WHO MONICA project. , 2004, Maturitas.

[32]  A. Alwan Global status report on noncommunicable diseases 2010. , 2011 .

[33]  L. Cantley,et al.  Obesity and Cancer Mechanisms: Cancer Metabolism. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  J. Ferlay,et al.  Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Observatory. , 2015, European journal of cancer.

[35]  E. Riboli,et al.  The second expert report, Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective , 2007 .

[36]  Z. Valerianova,et al.  Cancer burden of breast and gynecological cancers in Bulgaria: epidemiology and clinical aspects. , 2013, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.